Reinforcement-Based Treatment for Substance Use Disorders
Sprache: Englisch
Verlag: American Psychological Association, US, 2011
- Hardcover
- Neu

Anbieter: Rarewaves.com UK, London, Vereinigtes KönigreichRarewaves.com UK
Verkäufer:in bei AbeBooks seit 11. Juni 2025
Zustand: Neu
EUR 65,02
Anzahl: 4 verfügbar
In den WarenkorbArtikelbeschreibung des Verkäufers
This book is a clinician-friendly manual for implementing Reinforcement-Based Treatment (RBT), an intensive, evidence-based model for treating substance use disorders in community settings. RBT integrates the most effective behavioral techniques with motivational interviewing, highly individualized treatment plans, and case management. The goal is to help clients avoid substance use triggers and develop recreational outlets and support systems that are incompatible with substance use. Additionally, the model emphasizes customer service-a concept underemphasized in most programs-to ensure that clients receive positive reinforcement for attending treatment. Using a step-by-step approach that takes the reader through each treatment component, the authors provide clear, detailed, and practical case illustrations and a variety of useful forms and therapist scripts.
Bestandsnummer des Verkäufers LU-9781433810244
- Titel
- Reinforcement-Based Treatment for Substance Use Disorders
- Autor
- L. Michelle Tuten, Maxine L. Stitzer, Cindy Schaeffer, Hendree Jones
- Verlag
- American Psychological Association, US
- Erscheinungsjahr
- 2011
- Zustand
- New
- Einband
- Hardback
- Sprache
- Englisch
- ISBN-10
- 1433810247
- ISBN-13
- 9781433810244
- Auflage
- Illustrated.
- Abmessungen
- 19.05 x 1.91 x 26.67 cm
RBT integrates the most effective behavioral techniques with motivational interviewing, highly individualized treatment plans, and case management. The goal is to help clients avoid substance use triggers and develop recreational outlets and support systems that are incompatible with substance use. Additionally, the model emphasizes customer service—a concept underemphasized in most programs—to ensure that clients receive positive reinforcement for attending treatment.
Using a step-by-step approach that takes the reader through each treatment component, the authors provide clear, detailed, and practical case illustrations and a variety of useful forms and therapist scripts.
„Inhaltsangabe“ gehört möglicherweise zu einer anderen Auflage dieses Titels.
Über die Autorin bzw. den Autor
Ms. Tuten is codeveloper of an intervention, Family-Based Recovery, designed to treat families referred to child protective services for abuse or neglect associated with substance use. She has 12 years of experience in the study and implementation of evidence-based practices.
Hendree E. Jones, PhD, is a licensed psychologist in the state of Maryland and a professor in both the Department of Psychiatry and Behavioral Sciences and the Department of Obstetrics and Gynecology at Johns Hopkins University School of Medicine. Dr. Jones is the director of research for the Center for Addiction and Pregnancy and the executive program director of Cornerstone Drug and Alcohol Treatment Program. She also has an appointment as a senior research psychologist at Research Triangle Institute International.
Since 1994, Dr. Jones has been continuously funded by National Institute on Drug Abuse (NIDA) as a principal investigator designing and leading studies that focus on the in utero exposure to abused substances. She has published over 90 peer-reviewed publications, several book chapters, editorial letters, and non-peer-reviewed articles for clinicians.
Dr. Jones has served on numerous review panels for NIDA, the National Institute on Alcohol Abuse and Alcoholism, the Substance Abuse and Mental Health Services Administration, and the Institute of Medicine. She has held multiple leadership positions within APA's Division 28 (Psychopharmacology and Substance Abuse) and is currently president-elect. She is a member of the Women's Health Research Coalition, the College on the Problems of Drug Dependence, and a fellow of both the Maryland Psychological Association and APA. She currently serves on several editorial boards for peer-reviewed journals in the field of addiction.
Cindy M. Schaeffer, PhD, received her doctorate in child clinical psychology from the University of Missouri–Columbia and completed a postdoctoral fellowship in prevention science at the Johns Hopkins Bloomberg School of Public Health. The focus of her training and research has been in understanding the developmental trajectories that lead to juvenile offending and adolescent substance abuse and developing multisystemic (i.e., family, peer, school, community) interventions to address these problems.
Dr. Schaeffer is now an associate professor in the Department of Psychiatry and Behavioral Sciences at the Medical University of South Carolina and a member of the Family Services Research Center faculty. Currently, her research involves developing and evaluating an ecologically based intervention aimed at improving the relationships of youth at risk for serious antisocial behavior with prosocial peers and adapting multisystemic therapy for families in which there is substantiated child abuse or neglect and caregiver substance abuse by incorporating Reinforcement-Based Treatment.
Maxine L. Stitzer, PhD, is a research psychologist and professor in the Department of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine. At Johns Hopkins University, she conducts clinical research at the Behavioral Pharmacology Research Unit, a nationally recognized drug abuse research laboratory. Her extensive grant-supported research program has focused on pharmacological and behavioral approaches to the treatment of substance abuse and reflects active research interests in illicit drug abuse and tobacco dependence.
She has published over 200 scientific papers, coedited a book on methadone treatment, and founded the Cornerstone Treatment Research Clinic at Johns Hopkins University, where Reinforcement-Based Treatment has been developed and researched. She is well-known for her work on contingent incentive approaches in substance abuse treatment, which are designed to enhance motivation for positive behavior change, including abstinence from drug use. She has been the recipient of numerous federal research grants and several awards for outstanding contributions to behavioral science research.
She currently heads the Mid-Atlantic Node of the National Institute on Drug Abuse Clinical Trials Network, a project in which researchers and clinicians work together to test validated treatment methods in community clinics and disseminate these methods into service delivery.
L. Michelle Tuten, MSW, LCSW-C, is an assistant professor in the Department of Psychiatry at Johns Hopkins University School of Medicine, program director of the Cornerstone Drug and Alcohol Treatment Program, and deputy research director of the Center for Addiction and Pregnancy in Baltimore, Maryland. She is a coinvestigator on several grants funded by the National Institute on Drug Abuse that examine the efficacy of motivational incentives and other behavioral interventions, including Reinforcement-Based Treatment, and she regularly conducts trainings on evidence-based models for treating substance use disorders.
Ms. Tuten is codeveloper of an intervention, Family-Based Recovery, designed to treat families referred to child protective services for abuse or neglect associated with substance use. She has 12 years of experience in the study and implementation of evidence-based practices.
Hendree E. Jones, PhD, is a licensed psychologist in the state of Maryland and a professor in both the Department of Psychiatry and Behavioral Sciences and the Department of Obstetrics and Gynecology at Johns Hopkins University School of Medicine. Dr. Jones is the director of research for the Center for Addiction and Pregnancy and the executive program director of Cornerstone Drug and Alcohol Treatment Program. She also has an appointment as a senior research psychologist at Research Triangle Institute International.
Since 1994, Dr. Jones has been continuously funded by National Institute on Drug Abuse (NIDA) as a principal investigator designing and leading studies that focus on the in utero exposure to abused substances. She has published over 90 peer-reviewed publications, several book chapters, editorial letters, and non-peer-reviewed articles for clinicians.
Dr. Jones has served on numerous review panels for NIDA, the National Institute on Alcohol Abuse and Alcoholism, the Substance Abuse and Mental Health Services Administration, and the Institute of Medicine. She has held multiple leadership positions within APA's Division 28 (Psychopharmacology and Substance Abuse) and is currently president-elect. She is a member of the Women's Health Research Coalition, the College on the Problems of Drug Dependence, and a fellow of both the Maryland Psychological Association and APA. She currently serves on several editorial boards for peer-reviewed journals in the field of addiction.
Cindy M. Schaeffer, PhD, received her doctorate in child clinical psychology from the University of Missouri–Columbia and completed a postdoctoral fellowship in prevention science at the Johns Hopkins Bloomberg School of Public Health. The focus of her training and research has been in understanding the developmental trajectories that lead to juvenile offending and adolescent substance abuse and developing multisystemic (i.e., family, peer, school, community) interventions to address these problems.
Dr. Schaeffer is now an associate professor in the Department of Psychiatry and Behavioral Sciences at the Medical University of South Carolina and a member of the Family Services Research Center faculty. Currently, her research involves developing and evaluating an ecologically based intervention aimed at improving the relationships of youth at risk for serious antisocial behavior with prosocial peers and adapting multisystemic therapy for families in which there is substantiated child abuse or neglect and caregiver substance abuse by incorporating Reinforcement-Based Treatment.
Maxine L. Stitzer, PhD, is a research psychologist and professor in the Department of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine. At Johns Hopkins University, she conducts clinical research at the Behavioral Pharmacology Research Unit, a nationally recognized drug abuse research laboratory. Her extensive grant-supported research program has focused on pharmacological and behavioral approaches to the treatment of substance abuse and reflects active research interests in illicit drug abuse and tobacco dependence.
She has published over 200 scientific papers, coedited a book on methadone treatment, and founded the Cornerstone Treatment Research Clinic at Johns Hopkins University, where Reinforcement-Based Treatment has been developed and researched. She is well-known for her work on contingent incentive approaches in substance abuse treatment, which are designed to enhance motivation for positive behavior change, including abstinence from drug use. She has been the recipient of numerous federal research grants and several awards for outstanding contributions to behavioral science research.
She currently heads the Mid-Atlantic Node of the National Institute on Drug Abuse Clinical Trials Network, a project in which researchers and clinicians work together to test validated treatment methods in community clinics and disseminate these methods into service delivery.
„Über diesen Titel“ gehört möglicherweise zu einer anderen Auflage dieses Titels.
Rarewaves.com UK
London, Vereinigtes Königreich
Verkäufer:in bei AbeBooks seit 11. Juni 2025
Versandkosten von Vereinigtes Königreich nach USA
| Artikel | 60 bis 60 Werktage | 60 bis 60 Werktage |
|---|---|---|
| Erster Artikel | EUR 76,82 | EUR 118,18 |
Zahlungsarten
Unternehmensdaten der Verkäuferin bzw. des Verkäufers
RAREWAVES.COM LIMITED
Elsley Court, 20-22 Great Titchfield Street
London, Vereinigtes Königreich W1W 8BE
Widerrufsrecht
Wenn Sie Verbraucher sind, können Sie gemäß den folgenden Bestimmungen vom Vertrag zurücktreten. Verbraucher ist jede natürliche Person, die zu Zwecken handelt, die nicht ihrer kaufmännischen, gewerblichen, künstlerischen oder beruflichen Tätigkeit zugerechnet werden können.
Informationen zum Widerrufsrecht
Gesetzliches Widerrufsrecht
Sie haben das Recht, den Vertrag innerhalb von 14 Tagen ohne Angabe von Gründen zu widerrufen.
Die Widerrufsfrist beträgt 14 Tage ab dem Tag, an dem Sie oder ein von Ihnen benannter Dritter, der nicht der Transporteur ist, die letzte Ware oder den letzten Posten oder das letzte Exemplar in Besitz genommen hat.
Um das Widerrufsrecht auszuüben, füllen Sie auf unserer Website unter „Meine Einkäufe" in „Mein Nutzerkonto" eine eindeutige Erklärung elektronisch aus und senden Sie sie ab. Wir werden Ihnen unverzüglich eine Bestätigung über den Eingang eines solchen Widerrufs auf einem dauerhaften Datenträger (z. B. per E-Mail) übermitteln.
Um die Widerrufsfrist einzuhalten, reicht es aus, dass Sie Ihre Mitteilung über die Ausübung des Widerrufsrechts vor Ablauf der Widerrufsfrist absenden.
Auswirkungen des Widerrufs
Wenn Sie diesen Vertrag widerrufen, erstatten wir Ihnen alle Zahlungen, die wir von Ihnen erhalten haben, einschließlich der Lieferkosten (mit Ausnahme der zusätzlichen Kosten, die entstehen, wenn Sie eine andere Art der Lieferung als die von uns angebotene günstigste Standardlieferung gewählt haben).
Wir können einen Abzug von der Rückerstattung für den Wertverlust der gelieferten Waren vornehmen, wenn der Verlust auf eine unnötige Behandlung durch Sie zurückzuführen ist.
Wir werden die Rückerstattung unverzüglich und nicht später als 14 Tage nach dem Tag vornehmen, an dem wir über Ihre Entscheidung, diesen Vertrag zu widerrufen, informiert wurden.
Für die Rückerstattung verwenden wir dasselbe Zahlungsmittel, das Sie für die ursprüngliche Transaktion verwendet haben, es sei denn, Sie haben ausdrücklich etwas anderes vereinbart; in keinem Fall werden Ihnen aufgrund einer solchen Rückerstattung Gebühren berechnet.
Wir können die Rückzahlung verweigern, bis wir die Waren wieder zurückerhalten haben oder Sie den Nachweis erbracht haben, dass Sie die Waren zurückgesandt haben, je nachdem, was eher eintritt.
Sie müssen die Waren unverzüglich und in jedem Fall spätestens 14 Tage ab dem Tag, an dem Sie uns über den Widerruf dieses Vertrags unterrichten, an Rarewaves.com UK, Unit 144 The Lightbox, 111 Power Road, W4 5PY, London, London, United Kingdom, zurücksenden oder übergeben. Die Frist ist eingehalten, wenn Sie die Ware vor Ablauf der Frist von 14 Tagen zurücksenden. Sie müssen die direkten Kosten der Rücksendung der Waren tragen. Sie haften nur für einen etwaigen Wertverlust der Waren, der auf eine Behandlung zurückzuführen ist, die nicht zur Prüfung der Art, Eigenschaften und Funktionsweise der Waren erforderlich ist.
Ausnahmen vom Widerrufsrecht
Das Widerrufsrecht gilt nicht für:
- Die Lieferung von Zeitungen, Zeitschriften oder Magazinen mit Ausnahme von Abonnementverträgen; und
- Die Lieferung digitaler Inhalte, die nicht auf einem physischen Medium (z. B. auf einer CD oder DVD) geliefert werden, wenn Sie bei Ihrer Bestellung akzeptiert haben, dass wir mit der Lieferung beginnen können und dass Sie nach Beginn der Lieferung den Vertrag nicht mehr widerrufen können.
Versandbedingungen
Please note that we do not offer Priority shipping to any country.
We currently do not ship to the below countries:
Russia
Belarus
Ukraine
Please do not attempt to place orders with any of these countries as a ship to address - they will be cancelled.